Revance Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Revance Therapeutics Inc in one report.
- Save hours of research time and resources with
our up-to-date Revance Therapeutics Inc Strategy Report
- Understand Revance Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Revance Therapeutics Inc (Revance Therapeutics) focuses on the development and the commercialization of novel neuromodulators for a broad range of aesthetic and therapeutic indications. Focus on R&D, lead candidate, daxibotulinumtoxinA for injection, and improved product segment performance are its strengths even as confined geographical operations and product recall could be a major cause for concern to the company. Revance Therapeutics could benefit from its unmet clinical need for botulinum toxin treatment, new product launches, and growing market for facial aesthetics. However, high competition and stringent regulations could affect the company's growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer